NFE2L2 and lung cancer: Interestingly, two of the NRF2 target genes involved in ECM-receptor interactions – osteopontin (secreted phosphoprotein 1) and LAMB3 (laminin subunit beta 3) – have been identified as crucial pro-metastatic genes for lung cancer [58].